Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001641172-25-021425
Filing Date
2025-07-29
Accepted
2025-07-29 17:21:05
Documents
19

Document Format Files

Seq Description Document Type Size
1 S-3 forms-3.htm S-3 608439
2 EX-5.1 ex5-1.htm EX-5.1 30228
3 EX-5.2 ex5-2.htm EX-5.2 143345
4 EX-23.1 ex23-1.htm EX-23.1 4635
5 EX-23.2 ex23-2.htm EX-23.2 3501
6 CALCULATION OF FILING FEE TABLES ex107.htm   iXBRL EX-FILING FEES 41386
7 GRAPHIC forms-3_001.jpg GRAPHIC 13032
8 GRAPHIC ex5-1_001.jpg GRAPHIC 9087
9 GRAPHIC ex5-2_001.jpg GRAPHIC 8839
  Complete submission text file 0001641172-25-021425.txt   1010980

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT ex107_htm.xml XML 10817
Mailing Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD FL 7 BOSTON MA 02210 (646) 350-0702
Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

EIN.: 981034922 | State of Incorp.: X0
Type: S-3 | Act: 33 | File No.: 333-289056 | Film No.: 251163064
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)